Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.

J Formos Med Assoc

Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan. Electronic address:

Published: January 2020

AI Article Synopsis

  • Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare and challenging primary liver cancer that has distinct clinicopathological and radiological features, making preoperative diagnosis difficult.
  • A study analyzed data from 891 patients who underwent liver tumor surgery, identifying that cHCC-CCA patients had a high prevalence of hepatitis B and unusual radiological patterns, with lower disease-free survival (DFS) rates compared to hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).
  • Results indicated that factors like advanced tumor stage and high alpha-fetoprotein levels were linked to poorer outcomes, but the 5-year overall survival (OS) after surgery for c

Article Abstract

Background/purpose: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare primary liver cancer. Preoperative diagnosis of cHCC-CCA is difficult, and outcome of cHCC-CCA is obscured. Our study aimed to investigate the clinicopathological and radiological features of cHCC-CCA and compare their outcomes with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).

Methods: From August 2010 to December 2017, 891 patients undergoing liver tumor resection in Taipei Veterans General Hospital, including 30 patients with pathology-proven cHCC-CCA, 819 HCC, and 42 ICC were retrospectively reviewed. Radiological features of contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI) in patients with cHCC-CCA were reevaluated by a radiologist. Factors association with disease-free survival (DFS) and overall survival (OS) were analyzed.

Results: The mean age of cHCC-CCA, HCC and ICC was similar. Hepatitis B virus infection was prevalent in patients with cHCC-CCA (22/30, 73.3%). Most (70%) of the cHCC-CCA had atypical radiological pattern of HCC and belonged to classic type in pathological features. cHCC-CCA and ICC had worse DFS, but the 5-year OS of cHCC-CCA was substantial adequate after surgery. Of the 891 patients, male gender, advanced T stage, multiple tumor number, alpha-fetoprotein (AFP) level >20 ng/ml, cHCC-CCA, and ICC were factors associated with poor DFS in multivariable analysis. Older age, T stage 3 or 4, presence of macrovascular invasion, AFP >20 ng/mL, cHCC-CCA, and ICC were factors significantly associated with OS.

Conclusion: cHCC-CCA is associated with high risk of recurrence following surgical resection as compared with HCC. Closely post-operative monitoring is highly recommended.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jfma.2019.02.012DOI Listing

Publication Analysis

Top Keywords

chcc-cca
14
radiological features
12
chcc-cca icc
12
features chcc-cca
8
891 patients
8
hcc icc
8
patients chcc-cca
8
>20 ng/ml chcc-cca
8
icc factors
8
factors associated
8

Similar Publications

Article Synopsis
  • The study investigates the characteristics of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) and its association with microvascular invasion (MVI) using ultrasonography, particularly contrast-enhanced ultrasound (CEUS).
  • A retrospective analysis of 57 patients with cHCC-CCA found that those with MVI exhibited specific ultrasonographic features, such as larger tumor size and distinct CEUS patterns.
  • Results indicated that features like low echo halo, irregular rim-like enhancement, and early washout are significant risk factors for MVI, providing a predictive tool for clinicians.
View Article and Find Full Text PDF

Prognostic Impact of CCA Components in Combined Hepatocellular Carcinoma-Cholangiocarcinoma.

J Hepatocell Carcinoma

December 2024

Department of Radiology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, People's Republic of China.

Purpose: To investigate the differences of combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA) patients with a cholangiocarcinoma (CCA) component ≥ 30% or < 30% versus intrahepatic cholangiocarcinoma (iCCA) patients in recurrence-free survival (RFS) and overall survival (OS) prognoses.

Methods: Patients with cHCC-CCA and iCCA after surgery were recruited. All cHCC-CCA patients were divided into two subgroups (CCA components ≥ 30% and < 30%).

View Article and Find Full Text PDF

Primary hepatic carcinoma, comprising hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular cholangiocarcinoma (cHCC-CCA), ranks among the most common malignancies worldwide. The heterogeneity of tumors is a primary factor impeding the efficacy of treatments for primary hepatic carcinoma. Immunohistochemical markers may play a potential role in characterizing this heterogeneity, providing significant guidance for prognostic analysis and the development of personalized treatment plans for the patients with primary hepatic carcinoma.

View Article and Find Full Text PDF

Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion.

Mol Cancer

December 2024

Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, Ministry of Education, Sichuan University, Chengdu, 610041, Sichuan, P.R. China.

Combined hepatocellular-cholangiocarcinoma (cHCC-CCA), an extremely rare and underinvestigated subtype of primary liver cancer in children, generally has a poor prognosis and greater aggressiveness. Histological diagnosis of cHCC-CCA is difficult because of its diverse components, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). cHCC-CCA shares some genetic alterations with HCC and CCA.

View Article and Find Full Text PDF

Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a unique subtype of primary liver cancer displaying both hepatocytic and cholangiocytic differentiation. The development of effective treatments for cHCC-CCA remains challenging because of its high heterogeneity and lack of a suitable model system. Using a three-dimensional culture system, we successfully established two novel cHCC-CCA organoid lines from patients undergoing surgical resection for primary liver cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!